Publication | Closed Access

Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1b

Viral PersistenceHepatologyEconomic OutcomesHepatitis CViral HepatitisLong-term ClinicalClinical EpidemiologyAntiviral TherapyHepatitisVirologyChronic Viral InfectionInfection ControlPublic HealthAntiviral DrugMedicineEpidemiologyDaclatasvir Plus Asunaprevir